Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 28

1.

Yersinia pestis Pla Protein Thwarts T Cell Defense against Plague.

Smiley ST, Szaba FM, Kummer LW, Duso DK, Lin JS.

Infect Immun. 2019 Apr 23;87(5). pii: e00126-19. doi: 10.1128/IAI.00126-19. Print 2019 Mar.

PMID:
30804102
2.

Virtual memory CD8 T cells expanded by helminth infection confer broad protection against bacterial infection.

Lin JS, Mohrs K, Szaba FM, Kummer LW, Leadbetter EA, Mohrs M.

Mucosal Immunol. 2019 Jan;12(1):258-264. doi: 10.1038/s41385-018-0100-x. Epub 2018 Oct 25.

3.

Zika virus infection in immunocompetent pregnant mice causes fetal damage and placental pathology in the absence of fetal infection.

Szaba FM, Tighe M, Kummer LW, Lanzer KG, Ward JM, Lanthier P, Kim IJ, Kuki A, Blackman MA, Thomas SJ, Lin JS.

PLoS Pathog. 2018 Apr 10;14(4):e1006994. doi: 10.1371/journal.ppat.1006994. eCollection 2018 Apr.

4.

TNFα and IFNγ but not perforin are critical for CD8 T cell-mediated protection against pulmonary Yersinia pestis infection.

Szaba FM, Kummer LW, Duso DK, Koroleva EP, Tumanov AV, Cooper AM, Bliska JB, Smiley ST, Lin JS.

PLoS Pathog. 2014 May 22;10(5):e1004142. doi: 10.1371/journal.ppat.1004142. eCollection 2014 May.

5.

Intranasal prophylaxis with CpG oligodeoxynucleotide can protect against Yersinia pestis infection.

Hickey AJ, Lin JS, Kummer LW, Szaba FM, Duso DK, Tighe M, Parent MA, Smiley ST.

Infect Immun. 2013 Jun;81(6):2123-32. doi: 10.1128/IAI.00316-13. Epub 2013 Apr 1.

6.

Fibrin facilitates both innate and T cell-mediated defense against Yersinia pestis.

Luo D, Lin JS, Parent MA, Mullarky-Kanevsky I, Szaba FM, Kummer LW, Duso DK, Tighe M, Hill J, Gruber A, Mackman N, Gailani D, Smiley ST.

J Immunol. 2013 Apr 15;190(8):4149-61. doi: 10.4049/jimmunol.1203253. Epub 2013 Mar 13.

7.

Gammaherpesvirus latency induces antibody-associated thrombocytopenia in mice.

Freeman ML, Burkum CE, Lanzer KG, Roberts AD, Pinkevych M, Itakura A, Kummer LW, Szaba FM, Davenport MP, McCarty OJ, Woodland DL, Smiley ST, Blackman MA.

J Autoimmun. 2013 May;42:71-9. doi: 10.1016/j.jaut.2012.11.005. Epub 2012 Dec 14.

8.

Immunity to the conserved influenza nucleoprotein reduces susceptibility to secondary bacterial infections.

Haynes L, Szaba FM, Eaton SM, Kummer LW, Lanthier PA, Petell AH, Duso DK, Luo D, Lin JS, Lefebvre JS, Randall TD, Johnson LL, Kohlmeier JE, Woodland DL, Smiley ST.

J Immunol. 2012 Nov 15;189(10):4921-9. doi: 10.4049/jimmunol.1201916. Epub 2012 Oct 1.

9.

Factor XI-deficient mice display reduced inflammation, coagulopathy, and bacterial growth during listeriosis.

Luo D, Szaba FM, Kummer LW, Johnson LL, Tucker EI, Gruber A, Gailani D, Smiley ST.

Infect Immun. 2012 Jan;80(1):91-9. doi: 10.1128/IAI.05568-11. Epub 2011 Oct 17.

10.

Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses.

Lanthier PA, Huston GE, Moquin A, Eaton SM, Szaba FM, Kummer LW, Tighe MP, Kohlmeier JE, Blair PJ, Broderick M, Smiley ST, Haynes L.

Vaccine. 2011 Oct 13;29(44):7849-56. doi: 10.1016/j.vaccine.2011.07.093. Epub 2011 Aug 2.

11.

Protective roles for fibrin, tissue factor, plasminogen activator inhibitor-1, and thrombin activatable fibrinolysis inhibitor, but not factor XI, during defense against the gram-negative bacterium Yersinia enterocolitica.

Luo D, Szaba FM, Kummer LW, Plow EF, Mackman N, Gailani D, Smiley ST.

J Immunol. 2011 Aug 15;187(4):1866-76. doi: 10.4049/jimmunol.1101094. Epub 2011 Jul 1.

12.

Yersinia pestis YopE contains a dominant CD8 T cell epitope that confers protection in a mouse model of pneumonic plague.

Lin JS, Szaba FM, Kummer LW, Chromy BA, Smiley ST.

J Immunol. 2011 Jul 15;187(2):897-904. doi: 10.4049/jimmunol.1100174. Epub 2011 Jun 8.

13.

IL-17 contributes to cell-mediated defense against pulmonary Yersinia pestis infection.

Lin JS, Kummer LW, Szaba FM, Smiley ST.

J Immunol. 2011 Feb 1;186(3):1675-84. doi: 10.4049/jimmunol.1003303. Epub 2010 Dec 20.

14.

Systemic but not local infections elicit immunosuppressive IL-10 production by natural killer cells.

Perona-Wright G, Mohrs K, Szaba FM, Kummer LW, Madan R, Karp CL, Johnson LL, Smiley ST, Mohrs M.

Cell Host Microbe. 2009 Dec 17;6(6):503-12. doi: 10.1016/j.chom.2009.11.003.

15.

D27-pLpxL, an avirulent strain of Yersinia pestis, primes T cells that protect against pneumonic plague.

Szaba FM, Kummer LW, Wilhelm LB, Lin JS, Parent MA, Montminy-Paquette SW, Lien E, Johnson LL, Smiley ST.

Infect Immun. 2009 Oct;77(10):4295-304. doi: 10.1128/IAI.00273-09. Epub 2009 Jul 20.

16.

gamma-Herpesvirus-induced protection against bacterial infection is transient.

Yager EJ, Szaba FM, Kummer LW, Lanzer KG, Burkum CE, Smiley ST, Blackman MA.

Viral Immunol. 2009 Feb;22(1):67-72. doi: 10.1089/vim.2008.0086.

17.

Antibodies and cytokines independently protect against pneumonic plague.

Kummer LW, Szaba FM, Parent MA, Adamovicz JJ, Hill J, Johnson LL, Smiley ST.

Vaccine. 2008 Dec 9;26(52):6901-7. doi: 10.1016/j.vaccine.2008.09.063. Epub 2008 Oct 14.

18.

Gamma interferon suppresses erythropoiesis via interleukin-15.

Mullarky IK, Szaba FM, Kummer LW, Wilhelm LB, Parent MA, Johnson LL, Smiley ST.

Infect Immun. 2007 May;75(5):2630-3. Epub 2007 Feb 16.

19.

In situ assays demonstrate that interferon-gamma suppresses infection-stimulated hepatic fibrin deposition by promoting fibrinolysis.

Mullarky IK, Szaba FM, Winchel CG, Parent MA, Kummer LW, Mackman N, Johnson LL, Smiley ST.

J Thromb Haemost. 2006 Jul;4(7):1580-7.

21.

Tumor necrosis factor alpha and gamma interferon, but not hemorrhage or pathogen burden, dictate levels of protective fibrin deposition during infection.

Mullarky IK, Szaba FM, Berggren KN, Kummer LW, Wilhelm LB, Parent MA, Johnson LL, Smiley ST.

Infect Immun. 2006 Feb;74(2):1181-8.

22.

Cell-mediated protection against pulmonary Yersinia pestis infection.

Parent MA, Berggren KN, Kummer LW, Wilhelm LB, Szaba FM, Mullarky IK, Smiley ST.

Infect Immun. 2005 Nov;73(11):7304-10.

23.

Infection-stimulated fibrin deposition controls hemorrhage and limits hepatic bacterial growth during listeriosis.

Mullarky IK, Szaba FM, Berggren KN, Parent MA, Kummer LW, Chen W, Johnson LL, Smiley ST.

Infect Immun. 2005 Jul;73(7):3888-95.

24.

Exacerbated susceptibility to infection-stimulated immunopathology in CD1d-deficient mice.

Smiley ST, Lanthier PA, Couper KN, Szaba FM, Boyson JE, Chen W, Johnson LL.

J Immunol. 2005 Jun 15;174(12):7904-11.

25.

Yersinia pestis V protein epitopes recognized by CD4 T cells.

Parent MA, Berggren KN, Mullarky IK, Szaba FM, Kummer LW, Adamovicz JJ, Smiley ST.

Infect Immun. 2005 Apr;73(4):2197-204.

26.

Intact type 1 immunity and immune-associated coagulative responses in mice lacking IFN gamma-inducible fibrinogen-like protein 2.

Hancock WW, Szaba FM, Berggren KN, Parent MA, Mullarky IK, Pearl J, Cooper AM, Ely KH, Woodland DL, Kim IJ, Blackman MA, Johnson LL, Smiley ST.

Proc Natl Acad Sci U S A. 2004 Mar 2;101(9):3005-10. Epub 2004 Feb 19.

27.

Fibrin-mediated protection against infection-stimulated immunopathology.

Johnson LL, Berggren KN, Szaba FM, Chen W, Smiley ST.

J Exp Med. 2003 Mar 17;197(6):801-6. Epub 2003 Mar 10.

28.

Supplemental Content

Loading ...
Support Center